Clinical Trials Browser

Interventional × HER2-positive Advanced Breast Cancer × 90 days × Clear all

NCT07047365 2026-02-02

TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer

Phase 3 Recruiting

HER2-positive Advanced Breast Cancer